China Money Network
Login
Join

C-Bridge Capital Leads $35M New Round In Ascletis

  • September 3, 2015 — 14:58 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese pharmaceutical start-up Ascletis has completed RMB220 million (US$35 million) new round of financing led by C-Bridge Capital, according to a company announcement. Chinese drug... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: